EP1494712A4 - Multiple sclerosis-related immunoglobulin derived proteins, compositions, methods and uses - Google Patents

Multiple sclerosis-related immunoglobulin derived proteins, compositions, methods and uses

Info

Publication number
EP1494712A4
EP1494712A4 EP03716871A EP03716871A EP1494712A4 EP 1494712 A4 EP1494712 A4 EP 1494712A4 EP 03716871 A EP03716871 A EP 03716871A EP 03716871 A EP03716871 A EP 03716871A EP 1494712 A4 EP1494712 A4 EP 1494712A4
Authority
EP
European Patent Office
Prior art keywords
compositions
methods
multiple sclerosis
derived proteins
immunoglobulin derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03716871A
Other languages
German (de)
French (fr)
Other versions
EP1494712A2 (en
Inventor
David Peritt
George Tracey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Biotech Inc
Original Assignee
Centocor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centocor Inc filed Critical Centocor Inc
Publication of EP1494712A2 publication Critical patent/EP1494712A2/en
Publication of EP1494712A4 publication Critical patent/EP1494712A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
EP03716871A 2002-03-26 2003-03-26 Multiple sclerosis-related immunoglobulin derived proteins, compositions, methods and uses Withdrawn EP1494712A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36789602P 2002-03-26 2002-03-26
US367896P 2002-03-26
PCT/US2003/009460 WO2003082206A2 (en) 2002-03-26 2003-03-26 Multiple sclerosis-related immunoglobulin derived proteins, compositions, methods and uses

Publications (2)

Publication Number Publication Date
EP1494712A2 EP1494712A2 (en) 2005-01-12
EP1494712A4 true EP1494712A4 (en) 2006-06-14

Family

ID=28675412

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03716871A Withdrawn EP1494712A4 (en) 2002-03-26 2003-03-26 Multiple sclerosis-related immunoglobulin derived proteins, compositions, methods and uses

Country Status (3)

Country Link
EP (1) EP1494712A4 (en)
AU (1) AU2003220557A1 (en)
WO (1) WO2003082206A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003083071A2 (en) * 2002-03-26 2003-10-09 Centocor, Inc. Diabetes-related immunoglobulin derived proteins, compositions, methods and uses
CN101052726A (en) * 2003-05-09 2007-10-10 森托科尔公司 IL-23p40 specific immunoglobulin derived proteins, compositions, methods and uses
WO2007147019A2 (en) 2006-06-13 2007-12-21 Zymogenetics, Inc. Il-17 and il-23 antagonists and methods of using the same
CN102245205A (en) * 2008-09-30 2011-11-16 贝勒研究院 Methods to reduce B-helper T cells to treat autoimmune diseases
ME02206B (en) * 2010-05-27 2016-02-20 Centocor Ortho Biotech Inc Insulin-like growth factor 1 receptor binding peptides
KR20120093002A (en) 2011-02-14 2012-08-22 (주)에이티젠 Method for diagnosing cancer and diagnosis kit using measurement of nk cell activity

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000056772A1 (en) * 1999-03-25 2000-09-28 Knoll Gmbh Human antibodies that bind human il-12 and methods for producing
WO2002097048A2 (en) * 2001-05-30 2002-12-05 Centocor, Inc. ANTI-p40 IMMUNOGLOBULIN DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6902734B2 (en) * 2000-08-07 2005-06-07 Centocor, Inc. Anti-IL-12 antibodies and compositions thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000056772A1 (en) * 1999-03-25 2000-09-28 Knoll Gmbh Human antibodies that bind human il-12 and methods for producing
WO2002097048A2 (en) * 2001-05-30 2002-12-05 Centocor, Inc. ANTI-p40 IMMUNOGLOBULIN DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES

Also Published As

Publication number Publication date
AU2003220557A1 (en) 2003-10-13
WO2003082206A3 (en) 2004-03-04
AU2003220557A8 (en) 2003-10-13
WO2003082206A2 (en) 2003-10-09
EP1494712A2 (en) 2005-01-12

Similar Documents

Publication Publication Date Title
EP1623011A4 (en) IL-23p40 SPECIFIC IMMUNOGLOBULIN DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES
AU2003223497A8 (en) Asthma-related anti-il-13 immunoglobulin derived proteins, compositions, methods and uses
EP1578930A4 (en) Cngh0004 polypeptides, antibodies, compositions, methods and uses
EP1644416A4 (en) Engineered anti-target immunoglobulin derived proteins, compositions, methods and uses
AU2002314825A1 (en) Anti-p40 immunoglobulin derived proteins, compositions, methods and uses
EP1542699A4 (en) Compounds, compositions, and methods employing same
HK1083509A1 (en) Anti-il-6 antibodies, compositions, methods and uses
AU2003262747A8 (en) Compounds, compositions, and methods
AU2003236527A8 (en) Compounds, compositions, and methods
AU2003265242A8 (en) Compounds, compositions, and methods
AU2003270015A8 (en) Compounds, compositions, and methods
AU2002359495A8 (en) Anti-tnf antibodies, compositions, methods and uses
AU2003266815A1 (en) Immunoglobulin compositions and methods
AU2003225976A1 (en) Anti-tnf antibodies, compositions, methods and uses
EP1711527A4 (en) Hla-dr-specific antibodies, compositions and methods
EP1539792A4 (en) Cngh0005 polypeptides, antibodies, compositions, methods and uses
AU2003237332A8 (en) Anti-relp fusion antibodies, compositions, methods and uses
AU2002365269A8 (en) Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses
IL156263A0 (en) Livin-derived peptides, compositions and uses thereof
AU2003220557A8 (en) Multiple sclerosis-related immunoglobulin derived proteins, compositions, methods and uses
AU2003267169A8 (en) Compounds, compositions and methods
AU2003297670A8 (en) P53-associated parkin-like cytoplasmic protein, and related compositions and methods
AU2003218432A8 (en) Diabetes-related immunoglobulin derived proteins, compositions, methods and uses
EP1501870A4 (en) Rsv proteins, antibodies, compositions, methods and uses
AU2002257052A8 (en) Reg-like protein immunoglobulin derived proteins, compositions, methods and uses

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20041025

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

A4 Supplementary search report drawn up and despatched

Effective date: 20060516

17Q First examination report despatched

Effective date: 20070608

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20071219